Naveen Kumar Tangudu

4PUBLICATIONS
24CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Plasma physics; fusion plasmas; electrical dischargesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 16, 2024
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression.

Naveen Kumar Tangudu, Raquel Buj, Hui Wang

|Nov 18, 2022
ATM inhibition drives metabolic adaptation via induction of macropinocytosis.

Zhentai Huang, Chi-Wei Chen, Raquel Buj

|May 10, 2022
53BP1: guarding the genome with a novel liquid weapon.

Naveen Kumar Tangudu, Katherine M Aird

|May 26, 2021
DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A.

Kelly E Leon, Raquel Buj, Elizabeth Lesko

Pageof 1